top

  Info

  • Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.

  Info

  • Utilizzare questo link per rimuovere la selezione effettuata.
3D Printing of Pharmaceuticals and Drug Delivery Devices
3D Printing of Pharmaceuticals and Drug Delivery Devices
Autore Lamprou Dimitrios A
Pubbl/distr/stampa Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2020
Descrizione fisica 1 electronic resource (436 p.)
Soggetto topico Medicine
Soggetto non controllato digital pharmacy
fused deposition modeling 3D printing
modified drug release
personalized medicines
telemedicine
three dimensional printing
additive manufacturing
3D printed drug products
printlets
personalised medicines
personalized pharmaceuticals
multiple units
spheroids
beads
acetaminophen
3D printing
fused filament fabrication
lignin
antioxidant materials
wound dressing
modified release
filament extrusion
fused layer modeling
theophylline
high API load
three-dimensional printing
fixed-dose combinations
tablets
multiple-layer dosage forms
stereolithography
vat polymerisation
fused deposition modeling
polylactic acid
chemical modification
MTT assay
biofilm formation
warfarin
semisolid extrusion 3D printing
inkjet printing
orodispersible film
oral powder
pediatric
hospital pharmacy
personalized medicine
on-demand manufacturing
drug delivery
micromedicine
drug development
micro-swimmer
micro-implant
oral dosages
microneedle
high-precision targeting
controlled release
geometry
resolution
feature size
release profile
vascularization
digital light processing technology
neural networks
optimization
prediction
FMD
pregabalin
gastric floating
complex structures
patient-specific
structural design
gums
Fused Deposition Modeling 3D Printing
processing parameters
pharmaceutical quality control
hot-melt extrusion
solid dosage forms
3D printed oral dosage forms
sustained drug release tablets
photopolymerization
paracetamol (acetaminophen)
aspirin (acetylsalicylic acid)
amorphous solid dispersion
poor solubility
fixed dose combination
stencil printing
pharmacoprinting
orodispersible discs
orodisperible films
floating systems
pulsatile release
chronotherapeutic delivery
wound-healing
3D bio-printing
pectin
propolis
cyclodextrin
3D bio-inks
fused deposition modelling
extrusion
vaginal meshes
mechanical properties
drug release
anti-infective devices
pelvic organ prolapse
stress urinary incontinence
gastro-retentive floating system
dissolution kinetics
implantable devices
subcutaneous
biodegradable
prolonged drug delivery
polymers
pharmaceuticals
extrusion-based 3D printing
fused deposition modeling (FDM)
pressure-assisted microsyringe (PAM)
materials
process
3D bioprinting
polymeric ink
pseudo-bone
implantable scaffold
computer-aided design (CAD) design
bioprinting
computer-aided design (CAD)
pharmaceutics
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910557780703321
Lamprou Dimitrios A  
Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2020
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Antitumor and Anti-HIV Agents from Natural Products
Antitumor and Anti-HIV Agents from Natural Products
Autore Nakagawa-Goto Kyoko
Pubbl/distr/stampa Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2020
Descrizione fisica 1 electronic resource (338 p.)
Soggetto topico Research & information: general
Soggetto non controllato natural phaeosphaeride A
antitumor activity
human tumor cell lines
HEF cell line
acute toxicity
aspidosperma-type
monoterpenoid indole alkaloids
antiproliferative activity
tubulin inhibitor
Bousigonia mekongensis
ursolic acid
DOTA
triterpenoids
cytotoxicity
diterpenoid alkaloids
human tumor cells
lipojesaconitine
delcosine
delpheline
kobusine
pseudokobusine
BRAF inhibitor
Mentha aquatica var. Kenting Water Mint
essential oil
chemoprevention
two-stage skin carcinogenesis
melanoma
curcumin analog
apoptosis
oxidative stress
drug–drug interaction
tamoxifen
taxol
cisplatin
Artemisia absinthium L.
antioxidants
total phenolic content
melanoma and breast cancer cell line
HaCaT cells
inflammation
breast cancer
cell cycle
flavonoids
reactive oxygen species
tumor suppression
antiretroviral agents
anti-HIV
marine metabolites
natural products
drug development
Ivalin
Carpesium divaricatum
hepatocellular carcinoma
mitochondria-mediated apoptosis
NF-κB
Hernandia nymphaeifolia
butanolides
lignan glycosides
coumarins
antiangiogenic
cancer
natural agents
chemistry
medicine
cancer stem cell
cervical cancer
pterostilbene
resveratrol
caffeic acid
cancer multidrug resistance
P-glycoprotein
phenolic acid
oxypeucedanin
Angelica dahurica
antiproliferation
G2/M phase cell cycle arrest
p53
SK-Hep-1
hepatoma cells
allyl isothiocyanate
benzyl isothiocyanate
sulforaphane
phenethyl isothiocyanate
bladder cancer
quercetin
oral squamous cell carcinoma cells
metastasis
cell cycle arrest
epithelial-to-mesenchymal transition
matrix metalloproteinase
transforming growth factor-β1
β-lapachone
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910557504803321
Nakagawa-Goto Kyoko  
Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2020
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Cell-Free Synthetic Biology
Cell-Free Synthetic Biology
Autore Hong Seok Hoon
Pubbl/distr/stampa MDPI - Multidisciplinary Digital Publishing Institute, 2020
Descrizione fisica 1 electronic resource (152 p.)
Soggetto non controllato genomically engineered E. coli
in vitro transcription-translation (TX-TL)
tPa
tissue plasminogen activator
in vitro translation
enzymes
DNA origami
antimicrobials
cell-free metabolic engineering (CFME)
cell-free transcription-translation
in vitro protein synthesis
cell-free metabolic engineering
E. coli crude extract preparation
chaperones
ischemic stroke
microsomes
sonication
cell-free protein synthesis
growth factors
artificial cell
unnatural protein
cell-free synthetic biology
rapid prototyping
drug development
unnatural amino acid
eukaryotic lysates
cell-free protein expression (CFPE)
riboregulator
synthetic biology
mathematical model
CFPS
cell-free protein synthesis (CFPS)
bioconversion platform
colicins
protein production
ISBN 3-03928-023-6
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910372785403321
Hong Seok Hoon  
MDPI - Multidisciplinary Digital Publishing Institute, 2020
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Drug delivery technology development in Canada / / special issue editors, Kishor M. Wasan, Ildiko Badea
Drug delivery technology development in Canada / / special issue editors, Kishor M. Wasan, Ildiko Badea
Pubbl/distr/stampa MDPI - Multidisciplinary Digital Publishing Institute, 2019
Descrizione fisica 1 electronic resource (352 p.)
Disciplina 615.1/900971
Soggetto topico Drug Delivery Systems - Canada
Soggetto non controllato encapsulation
biodistribution
pharmaceutics
targeted therapies
gambogic acid
GE11 peptide
formulation and dosage form development
transient modulation
ROESY NMR spectroscopy
bioaccessibility
polymeric micelle
pharmacological Inhibitors of HIF-1 and STAT3
nanoparticles
Vitamin D
drug discovery
EGFR-targeted therapy
translational research
clinical trials
doxorubicin
dissolution
drug development
permeation enhancers
Canada
plant
primary central nervous system lymphomas
photostabilizers
head and neck squamous cell carcinoma
mouse models
drug delivery systems
melphalan
hypoxia-induced chemoresistance
skin
virus
circadian clock
child friendly formulation
adenanthin
co-delivery
canola oil deodorizer distillate
Metaplex
innovation
controlled drug delivery
nifedipine
radiolabeling
amphotericin B
biological barriers
blood-brain barrier (BBB)
biologicals
lipid nanoparticles
oral formulation
phytosterols
medical devices
chronotherapy
oral
cationic gemini surfactant
route of administration
drug delivery
intra-arterial chemotherapy
developing world
sustained delivery
water miscible solvents
combination therapy
antibodies
throughput
magnetic fields
liposomes
medulloblastoma
drug-resistant melanoma
rosmarinic acid
topical formulation
TNO gastrointestinal model
gastrointestinal simulator
malignant gliomas
transdermal drug delivery
oral delivery
precision medicine
3D spheroid
flavonoids
staurosporine
DOX-Vit D
loading gradients
bacteriophage
phospholipid complex
triggered drug release
HIF-1
phage display
pharmacokinetics
emulsion
quercetin
cisplatin
parasitic infections
remote loading
HAV6 cadherin peptide
blood-brain barrier
inclusion complex
tocopherols
STAT3
ultrasound
liposome
fungal infections
magnetic resonance imaging (MRI)
MG63
model orange juice
radiation
cancer
mefloquine
small molecules
ISBN 3-03928-005-8
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910367736503321
MDPI - Multidisciplinary Digital Publishing Institute, 2019
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Emerging Therapeutic Approaches for Cystic Fibrosis
Emerging Therapeutic Approaches for Cystic Fibrosis
Autore Lopes-Pacheco Miquéias
Pubbl/distr/stampa Frontiers Media SA, 2020
Descrizione fisica 1 electronic resource (281 p.)
Soggetto topico Science: general issues
Pharmacology
Soggetto non controllato cystic fibrosis transmembrane conductance regulator
mutations
therapeutic approach
drug development
lung
inflammation
infection
modulators
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910557791403321
Lopes-Pacheco Miquéias  
Frontiers Media SA, 2020
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Enzyme Inhibitor from Marine Organisms
Enzyme Inhibitor from Marine Organisms
Autore Tischler Dirk
Pubbl/distr/stampa Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2020
Descrizione fisica 1 electronic resource (130 p.)
Soggetto topico Research & information: general
Soggetto non controllato sponge Monanchora pulchra
pentacyclic guanidine alkaloids
GH36 α-galactosidase
GH109 α-N-acetylgalactosaminidase
slow-binding irreversible inhibitor
monanchomycalin B
monanhocidin A
normonanhocidin A
Alzheimer′s disease
BACE1
acetylcholinesterase
in silico docking
phlorotannins
Ulva intestinalis
ACE inhibitory peptide
optimization
purification
structural identification
molecular docking
secondary metabolites
Mycosphaerella sp
asperchalasine
α-glucosidase
kinase inhibitors
drug development
marine natural products
inhibitor
macroalgae
marine fish
protease
Ulva ohnoi
functional annotation
structure–function relation
natural products
bioactives
enzyme inhibition
inactivation
marine bacteria
marine fungi
marine sponges
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910557107603321
Tischler Dirk  
Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2020
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Molecular Basis and Gene Therapies of Cystic Fibrosis
Molecular Basis and Gene Therapies of Cystic Fibrosis
Autore Engelhardt John
Pubbl/distr/stampa Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2020
Descrizione fisica 1 electronic resource (210 p.)
Soggetto topico Medicine
Soggetto non controllato cystic fibrosis
Staphylococcus aureus
superantigen
enterotoxin gene cluster
MRSA
exosomes
microvesicles
lung
primary cells
newborn screening
trypsinogen
CFTR gene
next generation sequencing
health policy
rAAV2/HBoV1
baculovirus
insect cells
lung microbiome
metagenomics
gut–lung axis
Cystic fibrosis
CFTR
transcriptomics
proteostasis
small molecules
drug development
common and new pathogenic variants
ethnic Russian population
gene therapy
cyclophosphamide
transient immunosuppression
incidence
survival
genotype-phenotype correlations
health policies
CFTR modulators
human nasal epithelial cells
organoids
biomarker
functional assay
pre-clinical in vitro models
CFTR-related disorders
molecular diagnosis
CFTR variants
Next Generation Sequencing (NGS)
disease liability
interpretation
penetrance
genotype-guided therapy
miRNA
airway basal cell
lentivirus
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910557392203321
Engelhardt John  
Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2020
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Novel Biomarkers in Alzheimer's Disease
Novel Biomarkers in Alzheimer's Disease
Autore Villa Chiara
Pubbl/distr/stampa Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021
Descrizione fisica 1 electronic resource (442 p.)
Soggetto topico Medicine
Soggetto non controllato flotillin
Alzheimer's disease
biomarker
exosomes
beta-amyloid
Tau
aging
biomarkers
cytokines
cognitive decline
metabolomics
neuroinflammation
multivariate analysis
physical performance
person-tailored
PET/CT
(18F)FDG
neuropsychological assessment
APP mutations
APOE alleles
PSEN1
PSEN2
germline mutations
late onset AD
early onset AD
familial AD
genetics of AD
mitochondrial spare respiratory capacity
mitochondrial
membrane potential
glycolytic reserve
semantic memory
phonemic fluency
episodic memory
neuropsychology
neuroimaging
mild cognitive impairment
EEG
TMS
obesity
diabetes
inflammation
Amyloid Beta
mitochondrial dysfunction
nutrition
omega-3 fatty acids
antioxidant
carotenoids
vitamin E
cognition
older adults
ageing
subjective cognitive decline
clock genes
Clock
ApoE
cardiovascular risk factors
Alzheimer disease
semantic priming
amyloid beta
cerebrospinal fluid
amyloid beta peptide
total tau
phosphorylated tau
diagnosis
drug development
clinical trials
diagnostic research
virus
bacteria
dementia
blood
behavioral and psychological symptoms of dementia (BPSD)
Alzheimer's disease (AD)
neuropsychiatry inventory scale (NPI)
endophenotypes
CART analysis
MTHFR
APOE
COMT
genetic variants
early diagnosis
biofluids
amyloid cascade hypothesis
glucose metabolism
adipose tissue dysfunction
energetic metabolism
lysosomes dysfunction
Type-3-Diabetes
neurodegeneration
amyloid
tau
soluble TREM2
NfL
Multiplex
SiMoA
diagnostics
messenger RNA
microRNA
neurotropic microbes
precision medicine
prognostics
synaptic biomarkers
neurofilament light chain
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910557129403321
Villa Chiara  
Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Novel Targets and Biomarkers in Solid Tumors
Novel Targets and Biomarkers in Solid Tumors
Autore Yang Dong-Hua
Pubbl/distr/stampa Frontiers Media SA, 2020
Descrizione fisica 1 electronic resource (285 p.)
Soggetto topico Science: general issues
Pharmacology
Soggetto non controllato solid tumor
target
biomarker
drug development
therapeutics
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910557743003321
Yang Dong-Hua  
Frontiers Media SA, 2020
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Novel Targets and Biomarkers in Solid Tumors, 2nd Edition
Novel Targets and Biomarkers in Solid Tumors, 2nd Edition
Autore Yang Dong-Hua
Pubbl/distr/stampa Frontiers Media SA, 2020
Descrizione fisica 1 electronic resource (285 p.)
Soggetto topico Science: general issues
Pharmacology
Soggetto non controllato solid tumor
target
biomarker
drug development
therapeutics
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910557430403321
Yang Dong-Hua  
Frontiers Media SA, 2020
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui